Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trialsMaria Vittoria Dieci, Valentina Guarneri, Aïcha Goubar et al.|Breast Cancer Research and Treatment|2017Cited by 28
Phase II, randomized trial of preoperative epirubicin-paclitaxel +/− gefitinib with biomarker evaluation in operable breast cancerValentina Guarneri, PierFranco Conte, Antonio Frassoldati et al.|Breast Cancer Research and Treatment|2007Cited by 21
Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approachAlessio Bruni, Vieri Scotti, Niccolò Giaj‐Levra et al.|PLoS ONE|2019Cited by 7
Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trialsMaria Vittoria Dieci, Valentina Guarneri, Antonio Frassoldati et al.|Breast Cancer Research and Treatment|2017Cited by 1
The standard of care for stage III NSCLC in the era of immunotherapy: An Italian national survey on the current pattern of care among Italian thoracic oncologistsAlessio Bruni, Vieri Scotti, Francesco Grossi et al.|Annals of Oncology|2018Cited by 1